Advances in Evaluation and Treatment of Severe Asthma (Part Two)

Link to article at PubMed

Med Clin North Am. 2022 Nov;106(6):987-999. doi: 10.1016/j.mcna.2022.08.004.

ABSTRACT

Providers caring for patients with severe, therapy-resistant asthma have novel options for their treatment. Administration of additional inhaled corticosteroids at the time of increased symptoms, a strategy referred to as anti-inflammatory rescue or AIR, has been proved to be effective in reducing the frequency of exacerbations and improving asthma-related quality of life. Long-acting muscarinic antagonists can be used in combination with long-acting beta-agonist bronchodilators for additional bronchodilation. The care of the patient with severe asthma must also include a strategy to help avoid severe, life-threatening asthma attacks, with intense patient education and a recommended survival toolkit.

PMID:36280341 | DOI:10.1016/j.mcna.2022.08.004

Leave a Reply

Your email address will not be published. Required fields are marked *